Literature DB >> 24123682

Cutting edge: type 1 diabetes occurs despite robust anergy among endogenous insulin-specific CD4 T cells in NOD mice.

Kristen E Pauken1, Jonathan L Linehan, Justin A Spanier, Nathanael L Sahli, Lokesh A Kalekar, Bryce A Binstadt, James J Moon, Daniel L Mueller, Marc K Jenkins, Brian T Fife.   

Abstract

Insulin-specific CD4(+) T cells are required for type 1 diabetes. How these cells are regulated and how tolerance breaks down are poorly understood because of a lack of reagents. Therefore, we used an enrichment method and tetramer reagents to track insulin-specific CD4(+) T cells in diabetes-susceptible NOD and resistant B6 mice expressing I-A(g7). Insulin-specific cells were detected in both strains, but they only became activated, produced IFN-γ, and infiltrated the pancreas in NOD mice. Unexpectedly, the majority of Ag-experienced cells in NOD mice displayed an anergic phenotype, but this population decreased with age as tolerance was lost. B6 mice expressing I-A(g7) were protected because insulin-specific cells did not become effector or anergic T cells but remained naive. These data suggest that NOD mice promote tolerance through anergy induction, but a small proportion of autoreactive T cells escape anergy to provoke type 1 diabetes.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24123682      PMCID: PMC3987747          DOI: 10.4049/jimmunol.1301927

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  24 in total

1.  Defective central tolerance induction in NOD mice: genomics and genetics.

Authors:  Silvia Zucchelli; Phil Holler; Tetsuya Yamagata; Matthew Roy; Christophe Benoist; Diane Mathis
Journal:  Immunity       Date:  2005-03       Impact factor: 31.745

2.  The insulin-specific T cells of nonobese diabetic mice recognize a weak MHC-binding segment in more than one form.

Authors:  Matteo G Levisetti; Anish Suri; Shirley J Petzold; Emil R Unanue
Journal:  J Immunol       Date:  2007-05-15       Impact factor: 5.422

Review 3.  The NOD mouse: a model of immune dysregulation.

Authors:  Mark S Anderson; Jeffrey A Bluestone
Journal:  Annu Rev Immunol       Date:  2005       Impact factor: 28.527

4.  Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice.

Authors:  Maki Nakayama; Norio Abiru; Hiroaki Moriyama; Naru Babaya; Edwin Liu; Dongmei Miao; Liping Yu; Dale R Wegmann; John C Hutton; John F Elliott; George S Eisenbarth
Journal:  Nature       Date:  2005-05-12       Impact factor: 49.962

5.  CD8+ T cell tolerance in nonobese diabetic mice is restored by insulin-dependent diabetes resistance alleles.

Authors:  Xavier Martinez; Huub T C Kreuwel; William L Redmond; Rebecca Trenney; Kara Hunter; Hugh Rosen; Nora Sarvetnick; Linda S Wicker; Linda A Sherman
Journal:  J Immunol       Date:  2005-08-01       Impact factor: 5.422

6.  Susceptible MHC alleles, not background genes, select an autoimmune T cell reactivity.

Authors:  Thomas Stratmann; Natalia Martin-Orozco; Valérie Mallet-Designe; Laurent Poirot; Dorian McGavern; Grigoriy Losyev; Cathleen M Dobbs; Michael B A Oldstone; Kenji Yoshida; Hitoshi Kikutani; Diane Mathis; Christophe Benoist; Kathryn Haskins; Luc Teyton
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

7.  Insulin-specific T cells are a predominant component of islet infiltrates in pre-diabetic NOD mice.

Authors:  D R Wegmann; M Norbury-Glaser; D Daniel
Journal:  Eur J Immunol       Date:  1994-08       Impact factor: 5.532

8.  Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice.

Authors:  D Daniel; R G Gill; N Schloot; D Wegmann
Journal:  Eur J Immunol       Date:  1995-04       Impact factor: 5.532

9.  Genetic absence of gamma-interferon delays but does not prevent diabetes in NOD mice.

Authors:  B Hultgren; X Huang; N Dybdal; T A Stewart
Journal:  Diabetes       Date:  1996-06       Impact factor: 9.461

10.  PD-1, but not PD-L1, expressed by islet-reactive CD4+ T cells suppresses infiltration of the pancreas during type 1 diabetes.

Authors:  Kristen E Pauken; Marc K Jenkins; Miyuki Azuma; Brian T Fife
Journal:  Diabetes       Date:  2013-04-04       Impact factor: 9.461

View more
  34 in total

1.  Adaptive Immunity to Leukemia Is Inhibited by Cross-Reactive Induced Regulatory T Cells.

Authors:  Luke S Manlove; Katherine E Berquam-Vrieze; Kristen E Pauken; Richard T Williams; Marc K Jenkins; Michael A Farrar
Journal:  J Immunol       Date:  2015-09-16       Impact factor: 5.422

2.  Reprogramming responsiveness to checkpoint blockade in dysfunctional CD8 T cells.

Authors:  Christine E Nelson; Lauren J Mills; Jennifer L McCurtain; Emily A Thompson; Davis M Seelig; Siddheshvar Bhela; Clare F Quarnstrom; Brian T Fife; Vaiva Vezys
Journal:  Proc Natl Acad Sci U S A       Date:  2019-01-24       Impact factor: 11.205

3.  Pathogen-reduced PRP blocks T-cell activation, induces Treg cells, and promotes TGF-β expression by cDCs and monocytes in mice.

Authors:  Johnson Q Tran; Marcus O Muench; Rachael P Jackman
Journal:  Blood Adv       Date:  2020-11-10

4.  Programmed Death-1 Culls Peripheral Accumulation of High-Affinity Autoreactive CD4 T Cells to Protect against Autoimmunity.

Authors:  Tony T Jiang; Tijana Martinov; Lijun Xin; Jeremy M Kinder; Justin A Spanier; Brian T Fife; Sing Sing Way
Journal:  Cell Rep       Date:  2016-11-08       Impact factor: 9.423

Review 5.  Type 1 diabetes pathogenesis and the role of inhibitory receptors in islet tolerance.

Authors:  Tijana Martinov; Brian T Fife
Journal:  Ann N Y Acad Sci       Date:  2019-04-26       Impact factor: 5.691

6.  Ectopic Expression of Self-Antigen Drives Regulatory T Cell Development and Not Deletion of Autoimmune T Cells.

Authors:  Thomas Lee; Maran L Sprouse; Pinaki Banerjee; Maria Bettini; Matthew L Bettini
Journal:  J Immunol       Date:  2017-08-23       Impact factor: 5.422

7.  Programmed Death-1 Restrains the Germinal Center in Type 1 Diabetes.

Authors:  Tijana Martinov; Linnea A Swanson; Elise R Breed; Christopher G Tucker; Alexander J Dwyer; Jenna K Johnson; Jason S Mitchell; Nathanael L Sahli; Joseph C Wilson; Lovejot M Singh; Kristin A Hogquist; Justin A Spanier; Brian T Fife
Journal:  J Immunol       Date:  2019-07-19       Impact factor: 5.422

8.  Perinatal tolerance to proinsulin is sufficient to prevent autoimmune diabetes.

Authors:  Gaurang Jhala; Jonathan Chee; Prerak M Trivedi; Claudia Selck; Esteban N Gurzov; Kate L Graham; Helen E Thomas; Thomas Wh Kay; Balasubramanian Krishnamurthy
Journal:  JCI Insight       Date:  2016-07-07

9.  Cutting edge: identification of autoreactive CD4+ and CD8+ T cell subsets resistant to PD-1 pathway blockade.

Authors:  Kristen E Pauken; Christine E Nelson; Tijana Martinov; Vaiva Vezys; Brian T Fife; Justin A Spanier; James R Heffernan; Nathanael L Sahli; Clare F Quarnstrom; Kevin C Osum; Jason M Schenkel; Marc K Jenkins; Bruce R Blazar
Journal:  J Immunol       Date:  2015-03-13       Impact factor: 5.422

Review 10.  Mechanisms of autoimmunity in the non-obese diabetic mouse: effector/regulatory cell equilibrium during peak inflammation.

Authors:  Nadir Askenasy
Journal:  Immunology       Date:  2016-02-08       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.